AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...

The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...

AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...

AstraZeneca (LSE:AZN) recently announced plans to invest $50 billion in the U.S. by 2030, including the development of a ...

ASTRAZENECA plans to spend US$50bn building manufacturing and research facilities in the US, following similar promises from ...

Meanwhile, President Trump continues to push reciprocal levies and reshoring efforts, while pharma prepares for escalating costs.

As part of a growing trend of pharmaceutical giants reshoring their operations, AstraZeneca (AZN) announced Monday that it will invest $50 billion in U.S. manufacturing by 2030. This is the company’s ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

Drug maker AstraZeneca has announced plans to invest 50 billion dollars (£37 billion) in the US over the next five years amid ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...